FDA product code GXY: Electrode, Cutaneous

GXY is the FDA product code for electrode, cutaneous. It is a Class II device, regulated under 21 CFR 882.1320 and reviewed by the Neurology panel. FDA has cleared 443 510(k) submissions under GXY, 45 in the last five years, from 255 different applicants. The average 510(k) review took 127 days (median 90); 124 days on average over the last three years. FDA has posted 20 recalls for GXY devices, 4 initiated in the last five years.

Classification

FieldValue
Device nameElectrode, Cutaneous
Device classClass II
Regulation21 CFR 882.1320
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for GXY

YearClearancesAvg. review days
20179147
201814156
20199135
20204195
202112230
20225105
202313167
20247115
20256153
202614103

Compare with all 510(k) review times · Search every GXY clearance

Top GXY applicants

ApplicantClearancesLatest
Empi101990-06-08
Medtronic Vascular101988-07-18
Aspect Medical Systems, Inc.92009-10-23
Labeltape Meditect, Inc.91992-01-14
Axelgaard Mfg. Co., Ltd.82014-02-13

250 more applicants have GXY clearances. See the full list in Caduvo.

Most recent GXY clearances

510(k)ApplicantDeviceDecision dateReview days
K262755Bionit Labs SrlWave Electrode;Remote Wave Electrode2026-11-0695
K263666Biowave CorporationBioWave BioWraps2026-11-0531
K262664Bozhou Rongjian Medical Appliance Co., Ltd.Rongjian Self-adhesive Electrode2026-10-2082
K262654Zhejiang Qiangnao Technology Co.,LtdDexus Prosthetic System (MSL2, MSR2)2026-08-2728
K260578Ambu A/SAmbu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu® NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu® NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US)2026-07-14144

Recalls for GXY devices

20 product recalls in 10 recall events; 4 initiated in the last five years and 4 still open. Most recent: 2023-10-02.

YearRecalls
20222
20232

Frequently asked questions

What is FDA product code GXY?

GXY is the FDA product code for electrode, cutaneous. It is a Class II device, regulated under 21 CFR 882.1320 and reviewed by the Neurology panel.

What device class is GXY?

Class II, regulation 21 CFR 882.1320. Typical premarket route: 510(k).

How long does a 510(k) take for product code GXY?

Across 443 cleared submissions the average was 127 days from receipt to decision (median 90).

Which companies have the most GXY clearances?

Empi (10); Medtronic Vascular (10); Aspect Medical Systems, Inc. (9); Labeltape Meditect, Inc. (9); Axelgaard Mfg. Co., Ltd. (8).

Have GXY devices been recalled?

Yes: 20 product recalls across 10 recall events; the most recent began 2023-10-02.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times